Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion

Juan Carlos Mesa Guti&eacute;rrez, Luis Arias Barquet, Josep Maria Caminal Mitjana, Sergi Prades Almolda, N&ugrave;ria Planas Dom&egrave;nech, Octavi Pujol Goita, Marc Rubio Caso, Jorge Arruga GinebredaDepartment of Ophthalmology, Hospital Universitari de Bellvitge, L&amp...

Full description

Bibliographic Details
Main Authors:	Juan Carlos Mesa Guti&eacute;rrez, Luis Arias Barquet, Josep Maria Caminal Mitjana, Sergi Prades Almolda, N&ugrave;ria Planas Dom&egrave;nech, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-09-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/intravitreal-bevacizumab-avastin-in-the-treatment-of-macular-edema-sec-a2152

Similar Items

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
by: Kumar Atul, et al.
Published: (2007-01-01)

Intravitreal Bevacizumab (Avastin) Injection for Neovascular Glaucoma
by: Shahin Yazdani, et al.
Published: (2008-12-01)

Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
by: Subrata Mandal, et al.
Published: (2011-01-01)

Using intravitreal bevacizumab (Avastin®) – Indian Scenario
by: Atul Kumar, et al.
Published: (2017-01-01)

Pharmacokinetics of intravitreal bevacizumab (Avastin&reg;) in rabbits
by: Sinapis C, et al.
Published: (2011-05-01)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
by: Shaikh Saad
Published: (2008-01-01)

Acute onset of retinal detachment after posterior chamber phakic intraocular lens implantation
by: N&uacute;ria Planas Dom&egrave;nech, et al.
Published: (2008-03-01)

Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
by: J. Fernando Arevalo, et al.
Published: (2011-01-01)

Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
by: Sachdev Nishant, et al.
Published: (2007-01-01)

Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials
by: Hammad A Qazi
Published: (2012-01-01)

Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario
by: Prashant Jain, et al.
Published: (2017-01-01)

Quality of bevacizumab (Avastin®) repacked in single-use glass vials for intravitreal administration
by: Michelle A. A. Sugimoto, et al.

Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity
by: Shah Parag, et al.
Published: (2007-01-01)

Tratamento da retinopatia por radiação com injeção intravítrea de bevacizumab (Avastin®): relato de caso Treatment of radiation retinopathy with intravitreal injection of bevacizumab (Avastin®): case report
by: Marcelo Mendes Lavezzo, et al.
Published: (2010-08-01)

Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure
by: Monica Dom&eacute;nech, et al.
Published: (2010-04-01)

Is monthly retreatment with intravitreal bevacizumab (Avastin&reg;) necessary in neovascular age-related macular degeneration?
by: Nicola G Ghazi, et al.
Published: (2010-04-01)

Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity
by: Sangtam Tiakumzuk, et al.
Published: (2007-01-01)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
by: Beuy Joob, et al.
Published: (2012-01-01)

Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration
by: Luis Arias, et al.
Published: (2010-02-01)

The effect of intravitreal bevacizumab (Avastin&reg;) on ocular pulse amplitude in neovascular age-related macular degeneration
by: Ehud Rechtman, et al.
Published: (2011-01-01)

Uso de bevacizumab (avastin) sublesional en papilomatosis laríngea recurrente Sublesional use of bevacizumab (avastin) in recurrent laryngeal papillomatosis
by: Olenka Alcas Arce, et al.
Published: (2016-10-01)

Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer
by: Th&eacute;r&egrave;se H Franco, et al.
Published: (2008-10-01)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
by: Ahmed S Al-Hinai
Published: (2012-01-01)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
by: Ahmed S Al-Hinai, et al.
Published: (2011-01-01)

Bilateral idiopathic orbital inflammation 3 years before systemic Wegener&acute;s granulomatosis in a 7-year-old girl
by: Juan D Mart&iacute;nez-Guti&eacute;rrez, et al.
Published: (2008-06-01)

Uso do bevacizumab (Avastin®) na síndrome KID: relato de caso Use of bevacizumab (Avastin®) in KID syndrome: case report
by: Luiza Caye, et al.
Published: (2010-06-01)

Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin&reg;) for AMD followed by controlateral sympathetic ophthalmia
by: Dimitrios Brouzas, et al.
Published: (2009-08-01)

Pretreatment Clinical Variables Associated With the Response to Intravitreal Bevacisumab (Avastin) Injection In Patients With Persistent Diabetic Macular Edema
by: Fareed A. Warid AL-Laftah, et al.
Published: (2010-07-01)

Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema:a meta-analysis
by: Xiao-Ling Zhang, et al.
Published: (2013-08-01)

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema
by: Hassan Al-Dhibi, et al.
Published: (2014-01-01)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
by: Jeon S, et al.
Published: (2014-08-01)

The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea
by: Luiz F.M. Barros, et al.
Published: (2007-09-01)

Intravitreal diclofenac versus intravitreal bevacizumab in persistent diabetic macular edema: Anatomical and functional outcome
by: Amal ElBendary, et al.
Published: (2018-10-01)

Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
by: Shah Parag, et al.
Published: (2011-01-01)

Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial
by: Farhad Fazel, et al.
Published: (2020-01-01)

Switch from intravitreal bevacizumab to aflibercept for treatment of diabetic macular edema
by: Fernando Miguel Miranda Nogueira
Published: (2019)

Intravitreal Bevacizumab In Diabetic Macular Edema At RSUP Cipto Mangunkusumo in 2017
by: Andi Arus Victor, et al.
Published: (2019-09-01)

Intravitreal Bevacizumab for Pseudophakic Cystoid Macular Edema; a Systematic Review
by: Khalil Ghasemi Falavarjani, et al.
Published: (2012-01-01)

Characteristics of macular edema in behcet disease after intravitreal bevacizumab injection
by: Fariba Ghassemi, et al.
Published: (2017-01-01)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
by: Yalamanchi S, et al.
Published: (2011-10-01)

Cannot write session to /tmp/vufind_sessions/sess_26cvkhbsh3lfdopvd4p9i91r0t